It might be a bit of an exaggerated title, but I think think is going to spell the end of the large manufacturer stranglehold on the industry. The days of £2K wholesale prices for a pair of aids are likely done pretty soon. When you have £7k sales using £70 of actual hardware, there’s such an economic pressure to fill the gap between that it becomes irresistible to other players in the market.
Just look at the current car market, there’s been an explosion of ‘lookalike’ Chinese vehicles, all electric and about a third of the price of the European/US versions. The pressure within the industry is greater, and the barrier to entry is much lower. Especially because the engineering and assembly is already there (and in some cases abandoned). The only real step behind is the R+D advantage held by the manufacturers.
Now, if you buy the latest hearing devices, put them through a test lab capable of emulating real world situations, and feed the results to AI, all things being equal, you can write that result back into a chip. Bang goes you competitive advantage and for $100, you can punt out a device with an OnSemi chip and the best de-noising capabilities on the market.
The big boys might be able to continue to throw up walls around their supply lines for a few years, but they’re staring at a cliff-edge, unless they pull a rabbit out of a hat (like spousal voice recognition) in the next iteration. Today you can buy an aid that will allow you to self-test, prescribe and stream Bluetooth with ease up to a severe loss.
Sorry if you don’t do existential threats on a Sunday (or if you have Oticon shares), but the writing is genuinely on the wall - in large enough letters that it can be seen on the horizon. As to my game, I think there’s still an opportunity for the tactile portion of the industry to carry on, but if I was working at putting the widgets in the boxes, I’d be seriously looking at my long term options.
Enjoy your Sunday Lunch!
You’re ignoring this member’s posts.